Company Filing History:
Years Active: 1992
Title: Friedhelm Maywald: Innovator in Peptide Research
Introduction
Friedhelm Maywald is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of peptide research, particularly in the development of inhibitors that have potential pharmaceutical applications.
Latest Patents
Maywald holds a patent for a peptide known as the pancreatic secretory trypsin inhibitor (PSTI) and its variants. This invention relates to a peptide that possesses an amino acid sequence of PSTI, along with variants where one or more amino acids in the original sequence are substituted with different amino acids. These modified peptides exhibit an advantageously altered specificity in their inhibitory action. The patent also describes methods for preparing these peptides and their potential uses in pharmaceuticals.
Career Highlights
Friedhelm Maywald is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on innovative research and development in peptide technology.
Collaborations
Throughout his career, Maywald has collaborated with esteemed colleagues, including John Collins and Helmut Blocker. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Friedhelm Maywald's contributions to peptide research and his innovative patent for pancreatic secretory trypsin inhibitors highlight his role as a significant figure in the field. His work continues to influence pharmaceutical advancements and offers promising avenues for future research.